Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_assertion type Assertion NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_head.
- NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_assertion description "[Furthermore, NEFL physically associated with tuberous sclerosis complex 1 (TSC1), a known inhibitor of the mTOR pathway, and NEFL downregulation led to functional activation of mTOR pathway and consequentially conferred cisplatin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_provenance.
- NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_assertion evidence source_evidence_literature NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_provenance.
- NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_assertion SIO_000772 22246235 NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_provenance.
- NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_assertion wasDerivedFrom befree-2016 NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_provenance.
- NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_assertion wasGeneratedBy ECO_0000203 NP953319.RAy6uZ6s4yBB78C0G8ibbJkMb_JZL4lFFmmACqMJb5zqg130_provenance.